15-72376198-T-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NR_027262.1(HEXA-AS1):n.86T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.927 in 1,428,282 control chromosomes in the GnomAD database, including 621,600 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.82 ( 54665 hom., cov: 34)
Exomes 𝑓: 0.94 ( 566935 hom. )
Consequence
HEXA-AS1
NR_027262.1 non_coding_transcript_exon
NR_027262.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.137
Genes affected
HEXA-AS1 (HGNC:25810): (HEXA antisense RNA 1)
HEXA (HGNC:4878): (hexosaminidase subunit alpha) This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 15-72376198-T-C is Benign according to our data. Variant chr15-72376198-T-C is described in ClinVar as [Benign]. Clinvar id is 1264792.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-72376198-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.946 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEXA-AS1 | NR_027262.1 | n.86T>C | non_coding_transcript_exon_variant | Exon 1 of 1 | ||||
HEXA | NM_000520.6 | c.-226A>G | upstream_gene_variant | ENST00000268097.10 | NP_000511.2 | |||
HEXA | NM_001318825.2 | c.-226A>G | upstream_gene_variant | NP_001305754.1 | ||||
HEXA | NR_134869.3 | n.-184A>G | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEXA | ENST00000268097.10 | c.-226A>G | upstream_gene_variant | 1 | NM_000520.6 | ENSP00000268097.6 | ||||
ENSG00000260729 | ENST00000379915.4 | n.-226A>G | upstream_gene_variant | 2 | ENSP00000478716.1 |
Frequencies
GnomAD3 genomes AF: 0.822 AC: 125112AN: 152128Hom.: 54658 Cov.: 34
GnomAD3 genomes
AF:
AC:
125112
AN:
152128
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.940 AC: 1199206AN: 1276036Hom.: 566935 Cov.: 57 AF XY: 0.941 AC XY: 582549AN XY: 619186
GnomAD4 exome
AF:
AC:
1199206
AN:
1276036
Hom.:
Cov.:
57
AF XY:
AC XY:
582549
AN XY:
619186
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.822 AC: 125152AN: 152246Hom.: 54665 Cov.: 34 AF XY: 0.828 AC XY: 61656AN XY: 74452
GnomAD4 genome
AF:
AC:
125152
AN:
152246
Hom.:
Cov.:
34
AF XY:
AC XY:
61656
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3126
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Jun 19, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at